ASX - By Stock
|
RAP |
Re:
Ann: Becoming a substantial holder
|
|
cub40
|
93 |
35K |
2 |
05/09/22 |
05/09/22 |
ASX - By Stock
|
93
|
35K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
I'm getting out, good luck gents
|
|
cub40
|
195 |
69K |
3 |
05/09/22 |
05/09/22 |
ASX - By Stock
|
195
|
69K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Second Supplementary Scheme Booklet
|
|
cub40
|
255 |
69K |
16 |
30/08/22 |
30/08/22 |
ASX - By Stock
|
255
|
69K
|
16
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Second Supplementary Scheme Booklet
|
|
cub40
|
255 |
69K |
0 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
255
|
69K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Adjournment of Scheme Meeting to a date to be determined
|
|
cub40
|
193 |
55K |
11 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
193
|
55K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Correction to ASX announcement
|
|
cub40
|
70 |
20K |
27 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
70
|
20K
|
27
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Adjournment of Scheme Meeting to a date to be determined
|
|
cub40
|
193 |
55K |
36 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
193
|
55K
|
36
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Adjournment of Scheme Meeting to a date to be determined
|
|
cub40
|
193 |
55K |
31 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
193
|
55K
|
31
|
|
ASX - By Stock
|
RAP |
Re:
VOTE NO. AWAIT "BEST & FINAL" DECLARATION
|
|
cub40
|
313 |
88K |
12 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
313
|
88K
|
12
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
cub40
|
466 |
160K |
19 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
466
|
160K
|
19
|
|
ASX - By Stock
|
RAP |
Re:
HOW TO VOTE
|
|
cub40
|
123 |
36K |
19 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
123
|
36K
|
19
|
|
ASX - By Stock
|
RAP |
Re:
NO-Vote fundraising and mailing campaign
|
|
cub40
|
95 |
32K |
4 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
95
|
32K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
NO-Vote fundraising and mailing campaign
|
|
cub40
|
95 |
32K |
5 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
95
|
32K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
cub40
|
3.3K |
2.5M |
1 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
3.3K
|
2.5M
|
1
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
cub40
|
3.3K |
2.5M |
12 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
3.3K
|
2.5M
|
12
|
|
ASX - By Stock
|
RAP |
Re:
BOD Motive?
|
|
cub40
|
97 |
30K |
8 |
16/04/22 |
16/04/22 |
ASX - By Stock
|
97
|
30K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Channel 7 News
|
|
cub40
|
26 |
10K |
13 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
26
|
10K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
Ann: COVID-19 Clinical Studies Update
|
|
cub40
|
97 |
32K |
1 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
97
|
32K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
cub40
|
3.3K |
2.5M |
9 |
20/09/21 |
20/09/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar Presentation
|
|
cub40
|
159 |
44K |
9 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
159
|
44K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Subscription vs. Price per Cough
|
|
cub40
|
67 |
18K |
6 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
67
|
18K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
cub40
|
104 |
37K |
41 |
02/08/21 |
02/08/21 |
ASX - By Stock
|
104
|
37K
|
41
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Results and Investor Conference Call Notification
|
|
cub40
|
32 |
9.7K |
19 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
32
|
9.7K
|
19
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
cub40
|
3.3K |
2.5M |
15 |
14/07/21 |
14/07/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
15
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
cub40
|
3.3K |
2.5M |
25 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
25
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
cub40
|
3.3K |
2.5M |
50 |
24/06/21 |
24/06/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
50
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
cub40
|
3.3K |
2.5M |
9 |
15/06/21 |
15/06/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Continued Use of ResAppDx at COVID-19 Respiratory Clinic
|
|
cub40
|
232 |
70K |
7 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
232
|
70K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate extends European ResAppDx trial
|
|
cub40
|
84 |
29K |
19 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
84
|
29K
|
19
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate commences European ResAppDx trial
|
|
cub40
|
167 |
59K |
2 |
31/05/21 |
31/05/21 |
ASX - By Stock
|
167
|
59K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: First participant recruited in COVID-19 cough study
|
|
cub40
|
42 |
14K |
16 |
27/05/21 |
27/05/21 |
ASX - By Stock
|
42
|
14K
|
16
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate commences European ResAppDx trial
|
|
cub40
|
167 |
59K |
27 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
167
|
59K
|
27
|
|
ASX - By Stock
|
RAP |
Re:
Ann: First participant recruited in COVID-19 cough study
|
|
cub40
|
42 |
14K |
29 |
17/05/21 |
17/05/21 |
ASX - By Stock
|
42
|
14K
|
29
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Agreement with Ilara Health to sell ResAppDx in Kenya
|
|
cub40
|
224 |
50K |
7 |
10/05/21 |
10/05/21 |
ASX - By Stock
|
224
|
50K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Change of Director's Interest Notice - Chris Ntoumenopoulos
|
|
cub40
|
106 |
30K |
5 |
20/03/21 |
20/03/21 |
ASX - By Stock
|
106
|
30K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Resignation of Joint Company Secretary
|
|
cub40
|
16 |
6.2K |
24 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
16
|
6.2K
|
24
|
|
ASX - By Stock
|
RAP |
Re:
RAP/DOC
|
|
cub40
|
97 |
20K |
6 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
97
|
20K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Continued Use of ResAppDx at COVID-19 Respiratory Clinic
|
|
cub40
|
232 |
70K |
2 |
08/01/21 |
08/01/21 |
ASX - By Stock
|
232
|
70K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
cub40
|
3.3K |
2.5M |
2 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
3.3K
|
2.5M
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate to pilot ResAppDx for telehealth across Europe
|
|
cub40
|
95 |
30K |
13 |
09/11/20 |
09/11/20 |
ASX - By Stock
|
95
|
30K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
Competitive Threat to ResApp
|
|
cub40
|
120 |
35K |
26 |
05/11/20 |
05/11/20 |
ASX - By Stock
|
120
|
35K
|
26
|
|
ASX - By Stock
|
RAP |
Re:
Rap revenue phase
|
|
cub40
|
104 |
34K |
24 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
104
|
34K
|
24
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
cub40
|
245 |
66K |
1 |
30/10/20 |
30/10/20 |
ASX - By Stock
|
245
|
66K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Partners with largest Australian consumer healthcare network
|
|
cub40
|
58 |
18K |
11 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
58
|
18K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Partners with largest Australian consumer healthcare network
|
|
cub40
|
58 |
18K |
15 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
58
|
18K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
2020 commercialisation
|
|
cub40
|
648 |
225K |
1 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
648
|
225K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
2020 commercialisation
|
|
cub40
|
648 |
225K |
13 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
648
|
225K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
2020 commercialisation
|
|
cub40
|
648 |
225K |
13 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
648
|
225K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp Joins Startup Creasphere Digital Health Program
|
|
cub40
|
477 |
269K |
14 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
477
|
269K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Functional Testing of Handheld and Wearable Devices Complete
|
|
cub40
|
109 |
72K |
17 |
22/09/20 |
22/09/20 |
ASX - By Stock
|
109
|
72K
|
17
|
|